Cargando…
Anti-ghrelin antibodies in appetite suppression: recent advances in obesity pharmacotherapy
Obesity is a medical condition caused by accumulated excess body fat with negative impact on patients’ health, including decreased life expectancy. It has become a major health problem in most developed and developing countries, since the worldwide prevalence of obesity nearly doubled during the las...
Autores principales: | Altabas, Velimir, Zjačić-Rotkvić, Vanja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918252/ https://www.ncbi.nlm.nih.gov/pubmed/27471718 http://dx.doi.org/10.2147/ITT.S60398 |
Ejemplares similares
-
Recent Advances in Potential Clinical Application of Ghrelin in Obesity
por: Delporte, Christine
Publicado: (2012) -
The Role of Endothelial Progenitor Cells in Atherosclerosis and Impact of Anti-Lipemic Treatments on Endothelial Repair
por: Altabas, Velimir, et al.
Publicado: (2022) -
l-cysteine suppresses ghrelin and reduces appetite in rodents and humans
por: McGavigan, A K, et al.
Publicado: (2015) -
Recent advances in pharmacotherapy of glaucoma
por: Gupta, S. K., et al.
Publicado: (2008) -
Inflammation-related cytokines and their roles in gastroenteropancreatic neuroendocrine neoplasms
por: Mahečić, Davorka Herman, et al.
Publicado: (2020)